跳至主要内容
临床试验/NCT01306825
NCT01306825Unknown不适用

Clinical Evaluation of Daptomycin Bone Penetration

University Hospital, Strasbourg, France3 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
15
试验地点
3
主要终点
Patients' percentage of which the intra-osseous daptomycin concentration is ≥ 8 times MIC (if available) or ≥ 8 times critical concentration (if Bacteriological documentation is unavailable)

研究概览

简要总结

Bone and joint infections are commonly due to Gram-positive bacteria. Treatment of these infections is difficult because of the need of prolonged duration of antimicrobial agents in combination with surgical procedure. Moreover, in recent years, a growing resistance pattern to various antimicrobial agents has been observed for Gram-positive bacteria. Consequently, there is an urgent need for new drugs with high bone penetration for the treatment of those infections. The investigators hypothesized that daptomycin allow to achieve high concentrations in bone compartments.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Patients' percentage of which the intra-osseous daptomycin concentration is ≥ 8 times MIC (if available) or ≥ 8 times critical concentration (if Bacteriological documentation is unavailable)

时间窗: 5 min before started administration of daptomycin, 5 min after administration of daptomycin and at random after perfusion of daptomycin

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验